Advertisement
Screener

HALOZYME THERAPEUTICS, INC. (HALO) Auditor

HALOZYME THERAPEUTICS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-17: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Diego, California.
  • 2025-02-18: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Diego, California.
  • 2024-02-20: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Diego, California.
  • 2023-02-21: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location San Diego, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-172025-12-31Ernst & Young LLP42San Diego, CaliforniaYes
2025-02-182024-12-31Ernst & Young LLP42San Diego, CaliforniaYes
2024-02-202023-12-31Ernst & Young LLP42San Diego, CaliforniaYes
2023-02-212022-12-31Ernst & Young LLP42San Diego, CaliforniaYes
2022-02-222021-12-31Ernst & Young LLP42San Diego, CaliforniaYes
2021-02-232020-12-31Ernst & Young LLPSan Diego, CaliforniaYes
2020-02-242019-12-31Ernst & Young LLPSan Diego, California
2019-02-212018-12-31Ernst & Young LLPSan Diego, California
2018-02-202017-12-31Ernst & Young LLPSan Diego, California
2017-02-282016-12-31Ernst & Young LLPSan Diego, California
2016-02-292015-12-31Ernst & Young LLPSan Diego, California
2015-03-022014-12-31Ernst & Young LLPSan Diego, California
2014-02-282013-12-31Ernst & Young LLPSan Diego, California
2013-03-012012-12-31Ernst & Young LLPSan Diego, California
2012-03-122011-12-31Ernst & Young LLPSan Diego, California
2011-03-112010-12-31Young LLPSan Diego, California
2010-03-122009-12-31Young LLPSan Diego, California
2009-03-132008-12-31Young LLPSan Diego, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78